-
EP4357354
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4357354
| EP4357354 - EPITOPE PEPTIDE OF HUMAN ALPHA-SYNUCLEIN AND PHARMACEUTICAL COMPOSITION INCLUDING SAID PEPTIDE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 22.03.2024 Database last updated on 12.07.2024 | |
| Former | The international publication has been made Status updated on 23.12.2022 | Most recent event Tooltip | 12.07.2024 | Amendment by applicant | Applicant(s) | For all designated states Sumitomo Pharma Co., Ltd. 6-8, Doshomachi 2-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP | [2024/17] | Inventor(s) | 01 /
HASEZAKI, Takuya Suita-shi, Osaka 564-0053 / JP | 02 /
YAMADA, Kazuto Osaka-shi, Osaka 541-0045 / JP | 03 /
MATSUMOTO, Mitsuhiro Osaka-shi, Osaka 554-0022 / JP | [2024/17] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2024/17] | Application number, filing date | 22825079.1 | 17.06.2022 | [2024/17] | WO2022JP24263 | Priority number, date | JP20210101745 | 18.06.2021 Original published format: JP 2021101745 | [2024/17] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022265091 | Date: | 22.12.2022 | Language: | JA | [2022/51] | Type: | A1 Application with search report | No.: | EP4357354 | Date: | 24.04.2024 | Language: | EN | [2024/17] | Search report(s) | International search report - published on: | JP | 22.12.2022 | Classification | IPC: | C07K7/06, A61K39/00, A61P25/00, A61P25/16, A61P25/28, C07K19/00, C07K14/47, C12N15/12 | [2024/17] | CPC: |
A61K39/00 (EP);
A61K47/50 (EP);
A61P25/00 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
C07K14/47 (EP);
C07K19/00 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/17] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | EPITOP-PEPTID DES MENSCHLICHEN ALPHA-SYNUCLEINS UND PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DIESEM PEPTID | [2024/17] | English: | EPITOPE PEPTIDE OF HUMAN ALPHA-SYNUCLEIN AND PHARMACEUTICAL COMPOSITION INCLUDING SAID PEPTIDE | [2024/17] | French: | PEPTIDE ÉPITOPE DE L'ALPHA-SYNUCLÉINE HUMAINE ET COMPOSITION PHARMACEUTIQUE COMPRENANT LEDIT PEPTIDE | [2024/17] | Entry into regional phase | 16.01.2024 | Translation filed | 16.01.2024 | National basic fee paid | 16.01.2024 | Search fee paid | 16.01.2024 | Designation fee(s) paid | 16.01.2024 | Examination fee paid | Examination procedure | 16.01.2024 | Examination requested [2024/17] | 11.07.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 31.03.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]JP2011512363 (AFFIRIS AG) [Y] 1-17 * claims *; | [Y]JP2013502379 (AFFIRIS AG) [Y] 1-17 * claims *; | [Y]WO2017164409 (UNIV OSAKA [JP], et al) [Y] 6-17 * claims, paragraphs [0007], [0011], [0036], [0039] [0054] *; | [Y]WO2020212593 (AC IMMUNE SA [CH]) [Y] 1-17* claims, page 174, line 5 to page 189, line 14, tables 4, 5 *; | [YX]JP2021508672 (UNITED NEUROSCIENCE) [Y] 1, 3, 5-17 [X] 1 | by applicant | WO2004041067 | WO2009103105 | WO2017164409 | WO2018232369 | - MARIA J MARTI et al., "Clinical overview of the synucleinopathies", Mov Disord., (20030000), pages S21 - 7 | - GLENDA HALLIDAY et al., "Milestones in Parkinson's Disease-Clinical and Pathologic Features", Mov. Disord., (20110000), vol. 26, pages 1051 - 1021 | - HODAKA YAMAKADO et al., "a-Synuclein BAC transgenic mice as a model for Parkinson's disease manifested decreased anxiety-like behavior and hyperlocomotion", Neuro science Research, (20120000), vol. 73, doi:10.1016/j.neures.2012.03.010, pages 173 - 177, XP028419871 DOI: http://dx.doi.org/10.1016/j.neures.2012.03.010 | - KATSUYA ARAKI et al., "A small-angle X-ray scattering study of alpha-synuclein from human red blood cells", Sci Rep., (20160000), vol. 6, page 30473 | - R. B. MERRIFIELD et al., J. Am. Chem. Soc., (19630000), vol. 85, no. 14, pages 2149 - 2154 |